Comparison · NCT02740660-ffffd3cf
Caffeine 100mg / Albuterol 4mg vs Placebo: Number of Participants With Adverse Events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Caffeine 100mg / Albuterol 4mg vs Placebo: Number of Participants With Adverse Events. Trial comparisons, record NCT02740660-ffffd3cf. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02740660-ffffd3cf
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.833 | 0.436 | 0.97 | wilson | |
| Risk in group 2 | 0.333 | 0.0968 | 0.7 | wilson | |
| Risk difference, group 1 minus group 2 | 0.5 | -0.0403 | 0.773 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 2.5 | 0.763 | 8.19 | log | |
| Odds ratio, group 1 over group 2 | 10 | 0.648 | 154 | log | |
| Number needed to treat, for one more participant with the outcome on Caffeine 100mg / Albuterol 4mg than on Placebo | 2 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Caffeine 100mg / Albuterol 4mg | One capsule 3 times per day orally for a total of 8 weeks and family weight management counseling for a total of 8 weeks.~Caffeine 100mg / Albuterol 4mg~Family weight management counseling | 5 | 6 | OG000 |
| Group 2 | Placebo | One capsule 3 times per day orally for a total of 8 weeks and family weight management counseling for a total of 8 weeks.~Placebo~Family weight management counseling | 2 | 6 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants With Adverse Events
- Description
- Time frame
- Week 2, Week 4, Week 6, Week 8
- Population
Source ClinicalTrials.gov
Trial
- Title
- Body Composition Changes With Albuterol and Caffeine Versus Placebo in Adolescents
- NCT number
- NCT02740660
- Phases
- NA
- Conditions
- Pediatric Obesity
- Interventions
- Caffeine 100mg / Albuterol 4mg, Placebo, Family weight management counseling
- Lead sponsor
- Pennington Biomedical Research Center
- Results first posted
- 2019-09-25
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02740660?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02740660-ffffd3cf